EQNasdaqPharmaceutical PreparationsFiscal year ends December 31
Equillium, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.24+0.05 (+4.20%)
Close on Oct 19, 2026
- Market cap
- $138.64M
- P/E (TTM)
- –
- Dividend yield
- –
Equillium statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Equillium | Industry median |
|---|---|---|
| Market Cap | $78.63M | $164.85M |
| Enterprise Value | $21.46M | $87.06M |
| PB Ratio | 1.40 | 2.03 |
| P/TBV Ratio | 1.40 | 2.31 |
Income (trailing twelve months)
| Measure | Equillium | Industry median |
|---|---|---|
| Operating Income | -$19.30M | -$21.44M |
| Net Income | -$18.01M | -$22.46M |
| EBITDA | -$19.30M | -$16.91M |
Returns
| Measure | Equillium | Industry median |
|---|---|---|
| Return on Equity (ROE) | -59.0% | -53.1% |
| Return on Assets (ROA) | -50.7% | -41.0% |
| Return on Capital Employed (ROCE) | -34.4% | -37.8% |
Balance sheet
| Measure | Equillium | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $57.16M | $62.42M |
| Net Cash (Debt) | $57.16M | $15.68M |
| Net Cash Per Share | $0.90 | $0.66 |
| Equity (Book Value) | $56.02M | $48.79M |
| Book Value Per Share | $0.88 | $1.36 |
| Tangible Book Value | $56.02M | $23.06M |
| Working Capital | $55.50M | $75.77M |
Financial position
| Measure | Equillium | Industry median |
|---|---|---|
| Current Ratio | 23.40 | 3.30 |
| Quick Ratio | 23.07 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Equillium | Industry median |
|---|---|---|
| Operating Cash Flow | -$19.97M | -$12.35M |
| Capital Expenditures | -$118.00K | -$1.06M |
| Free Cash Flow | -$20.09M | -$20.28M |
| FCF Per Share | -$0.32 | -$0.42 |
Efficiency
| Measure | Equillium | Industry median |
|---|---|---|
| Profits Per Employee | -$1.29M | -$703.34K |
| Employee Count | 14 | 74 |
Dividends and yields
| Measure | Equillium | Industry median |
|---|---|---|
| Earnings Yield | -22.9% | -22.7% |
| FCF Yield | -25.6% | -9.07% |
Shares
| Measure | Equillium | Industry median |
|---|---|---|
| Shares Outstanding | 63,408,100 | 58,179,650 |
| Shares Change (YoY) | 157.2% | 11.1% |
| Shares Change (QoQ) | 0.29% | 0.54% |
| Float | 58,560,000 | 49,173,100 |
| Shares Held by Insiders | 7.65% | 11.6% |
| Shares Held by Institutions | 65.8% | 59.4% |
Scores
| Measure | Equillium | Industry median |
|---|---|---|
| Altman Z-Score | 12.45 | -0.24 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Equillium's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.